Be the first to like this
How this Report can Help -
CXOs / Directors / VPs
- First innovative report to provide insights on several new strategic/financial investors willing to fund your company’s growth.
- Identify key venture partners contribution and strategic positions on Company ’s Board.
- Detailed series co-investors details to identify best investors consortium for your needs.
- Access to Numerous deals, structure & size to analyze true value of business model.
- Identify new emerging players in drug funding, with their core team and funding preferences.
- De-risk the venture by getting real insights through a comprehensive picture.
- Infographics design with focused and interactive content, takes no time in filling knowledge gaps.
- Virtually cover all oncology focused funding deals occurs in past 10 years with their valuation sizes.
- Explore Top Investors and eliminate your hours of digital search and data curating.
- Spend quality time in analyzing finer funding details & decisions making.
- Identify paradigm shift in oncology drug funding; with 10 years of funding history covering 500+ companies and 3000+ Deals.
- Closely monitor wining deals and M&A activities by bringing more data under analysis.
Start-ups / Entrepreneurs
- Clearly identify - who will invest in your business and to which extent.
- Quickly navigate the complete profiles of focused Investors and their investment strategies.
- Identify the extent of funding in each round/series to meet your immediate and future needs.
- To design and negotiate on better financial plans to unlock the real value of innovation/assets.
- Directly get in touch with oncology focused Venture Partner through Linkedin & E-mail ID.
Number of Pages = 570 pages interactive pdf
Price = 1495 USD (if directly purchased through OmicsX online store or through wire transfer)
1995 USD (if purchase through Research and Market - An online research report store)